|
Market Closed -
TEL AVIV STOCK EXCHANGE
10:24:30 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 1,060.00 ILa | -1.03% |
|
-5.27% | -3.11% |
| Market Cap | 121M 0 39.48M 35.25M 32.89M 29.87M 56.22M 3.82B 56.76M 395M 154M 1.94B 148M 145M 6.25B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 249M 0 81.24M 72.55M 67.68M 61.48M 116M 7.87B 117M 813M 318M 4B 305M 298M 12.86B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.03% | ||
| 1 week | -5.27% | ||
| Current month | -5.27% | ||
| 1 month | -1.85% | ||
| 3 months | -1.40% | ||
| 6 months | -12.47% | ||
| Current year | -3.11% |
| 1 week | 1,050 |  | 1,153 |
| 1 month | 1,044 | | 1,237 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,740 |
| 5 years | 1,006 | | 2,610 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 1993-08-23 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 2018-10-31 |
| President | 80 | 2010-06-27 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 2010-06-24 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 2015-04-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.03% | -5.27% | -8.78% | -40.42% | 39.82M | |
| -1.61% | +1.72% | +38.30% | +106.93% | 1,060B | |
| -0.76% | -0.84% | +35.21% | +62.70% | 623B | |
| +0.39% | +4.81% | +17.81% | +83.77% | 480B | |
| -0.29% | -0.99% | +64.79% | +37.06% | 352B | |
| -2.03% | +1.03% | +22.25% | +42.16% | 345B | |
| -1.92% | -1.87% | +11.94% | +33.20% | 274B | |
| -2.36% | -3.16% | -6.95% | +8.68% | 249B | |
| -1.37% | +0.04% | +38.29% | +52.33% | 223B | |
| +0.17% | -0.27% | +24.40% | +96.82% | 182B | |
| Average | -1.06% | -0.86% | +23.73% | +48.32% | 378.8B | |
| Weighted average by Cap. | -1.05% | +0.04% | +30.64% | +68.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 105M 93.74M 87.44M 79.43M 149M 10.17B 151M 1.05B 411M 5.17B 394M 386M 16.61B | 301M 0 98.21M 87.7M 81.81M 74.32M 140M 9.51B 141M 982M 384M 4.83B 369M 361M 15.54B |
| Net income | 6.21M 0 2.02M 1.81M 1.69M 1.53M 2.88M 196M 2.91M 20.25M 7.92M 99.65M 7.6M 7.44M 320M | -18.07M -0 -5.9M -5.27M -4.91M -4.46M -8.4M -571M -8.48M -58.98M -23.07M -290M -22.14M -21.66M -933M |
| Net Debt | 127M 0 41.47M 37.03M 34.54M 31.38M 59.05M 4.02B 59.62M 415M 162M 2.04B 156M 152M 6.56B | 128M 0 41.77M 37.3M 34.79M 31.61M 59.48M 4.05B 60.06M 418M 163M 2.06B 157M 153M 6.61B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-08 | ILA 1,060.00 | -1.03% | 1,480 |
| 26-10-07 | ILA 1,071.00 | -2.28% | 152 |
| 26-10-06 | ILA 1,096.00 | +0.46% | 47 |
| 26-10-05 | ILA 1,091.00 | -7.23% | 10,403 |
| 26-10-01 | ILA 1,176.00 | +5.09% | 1,509 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
